المؤلفون: Montes, AF, Lopez, CL, Martinez, GA, Lopez, DP, Munoz, AML, Paredes, BG, Abad, DG, Lopez, CC, Fonseca, PJ, Plazas, JG, Doldan, MCL, de Castro, EM, Canovas, MS, Puyal, MT, Ayala, BL, Martel, IJ, Flores, ML, Carmona-Bayonas, A

المصدر: ONCOLOGIST
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

مصطلحات موضوعية: Survival, Antiangiogenic, Aflibercept, Prognosis, Colorectal cancer, Real-world data, Nomogram

URL الوصول: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::f0078608c3c4b9e12d13289b6915f17e
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2861

المؤلفون: J Gallego, Plazas, A, Arias-Martinez, A, Lecumberri, E, Martínez de Castro, A, Custodio, J M, Cano, R, Hernandez, A F, Montes, I, Macias, A, Pieras-Lopez, M, Diez, L, Visa, R V, Tocino, N Martínez, Lago, M L, Limón, M, Gil, P, Pimentel, M, Mangas, M, Granja, A M, Carnicero, C Hernández, Pérez, L G, Gonzalez, P, Jimenez-Fonseca, A, Carmona-Bayonas

المساهمون: Institut Català de la Salut, [Plazas JG] Medical Oncology Department, Hospital General Universitario de Elche, Elche. [Arias-Martinez A] Pharmacy Department, Hospital Universitario Germans Trias i Pujol, Barcelona. [Lecumberri A] Medical Oncology Department, Hospital Universitario de Navarra, Pamplona. [Martínez de Castro E] Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander. [Custodio A] Medical Oncology Department, Hospital Universitario La Paz, CIBERONC CB16/12/00398, Madrid. [Cano JM] Medical Oncology Department, Hospital General Universitario de Ciudad Real, Ciudad Real. [Diez M] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia
ESMO Open
r-FISABIO. Repositorio Institucional de Producción Científica
instname

مصطلحات موضوعية: Male, Cancer Research, Survival, Gastroesophageal cancer, neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales::neoplasias del esófago [ENFERMEDADES], Adenocarcinoma, survival, Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Esophageal Neoplasms [DISEASES], Esòfag - Càncer - Tractament, Quimioteràpia combinada, gastroesophageal cancer, Stomach Neoplasms, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Antineoplastic Combined Chemotherapy Protocols, gender, Humans, sex, Registries, Toxicity, Neoplasms::Neoplasms by Histologic Type::Neoplasms, Glandular and Epithelial::Carcinoma::Adenocarcinoma [DISEASES], neoplasias::neoplasias por tipo histológico::neoplasias glandulares y epiteliales::carcinoma::adenocarcinoma [ENFERMEDADES], terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], toxicity, Gender, Progression-Free Survival, Estómac - Càncer - Tractament, Oncology, Female, Sex

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1ef9ded898720cfd038ff341c83f787
http://hdl.handle.net/10230/54596

المؤلفون: Castillón JC; Servicio de Oncología Médica, Hospital Universitario Vall D'Hebron, Ps Vall d'Hebron, 119-129, 08035, Barcelona, Spain. jacapdevila@vhebron.net., Gordoa TA; Servicio de Oncología Médica, Hospital Universitario Ramón y Cajal, Madrid, Spain., Bayonas AC; Servicio de Oncología Médica, Hospital Universitario Morales Meseguer, Murcia, Spain., Carretero AC; Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, Spain., García-Carbonero R; Servicio de Oncología Médica, Hospital Universitario 12 de Octubre, Madrid, Spain., Pulido EG; Servicio de Oncología Médica, MD Anderson Cancer Center, Madrid, Spain., Fonseca PJ; Servicio de Oncología Médica, Hospital Universitario Central de Asturias, Oviedo, Spain., Lete AL; Servicio de Oncología Médica, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Huerta AS; Servicio de Oncología Médica, Hospital Universitari I Politècnic la Fe, Valencia, Spain., Plazas JG; Servicio de Oncología Médica, Hospital General Universitario de Elche, Alicante, Spain.

المصدر: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2023 Sep; Vol. 25 (9), pp. 2692-2706. Date of Electronic Publication: 2023 May 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Bronchial Neoplasms*/diagnosis , Bronchial Neoplasms*/therapy , Carcinoma, Neuroendocrine* , Neuroendocrine Tumors*/diagnosis , Neuroendocrine Tumors*/therapy, Humans ; Algorithms

المؤلفون: Plazas JG; Medical Oncology Department, Hospital General Universitario de Elche, Elche, Spain. Electronic address: j.gallegoplazas@gmail.com., Arias-Martinez A; Pharmacy Department, Hospital Universitario Germans Trias i Pujol, Barcelona, Spain., Lecumberri A; Medical Oncology Department, Hospital Universitario de Navarra, Pamplona, Spain., Martínez de Castro E; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain., Custodio A; Medical Oncology Department, Hospital Universitario La Paz, CIBERONC CB16/12/00398, Madrid, Spain., Cano JM; Medical Oncology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., Hernandez R; Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain., Montes AF; Medical Oncology Department, Complejo Hospitalario de Ourense, Ourense, Spain., Macias I; Medical Oncology Department, Hospital Universitario Parc Taulí, Sabadell, Spain., Pieras-Lopez A; Pharmacy Department, Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain., Diez M; Medical Oncology Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain., Visa L; Medical Oncology Department, Hospital Universitario El Mar, Barcelona, Spain., Tocino RV; Medical Oncology Department, Complejo Asistencial Universitario de Salamanca - ISBAL, Salamanca, Spain., Lago NM; Medical Oncology Department, Complejo Hospitalario Universitario de A Coruña, Coruña, Spain., Limón ML; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain., Gil M; Medical Oncology Department, Hospital General Universitario de Valencia - Ciberonc CB16/12/0035, Valencia, Spain., Pimentel P; Medical Oncology Department, Hospital Santa Lucía, Cartagena, Spain., Mangas M; Medical Oncology Department, Hospital Galdakao-Usansolo, Galdakao-Usansolo, Spain., Granja M; Medical Oncology Department, Hospital Universitario Clínico San Carlos, Madrid, Spain., Carnicero AM; Medical Oncology Department, Hospital San Pedro, Logroño, Spain., Pérez CH; Medical Oncology Department, Hospital Universitario Nuestra Señora de la Candelaria, Tenerife, Spain., Gonzalez LG; Medical Oncology Department, Hospital General Universitario de Alicante, Alicante, Spain., Jimenez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain., Carmona-Bayonas A; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, University of Murcia, IMIB, Murcia, Spain.

المصدر: ESMO open [ESMO Open] 2022 Jun; Vol. 7 (3), pp. 100514. Date of Electronic Publication: 2022 Jun 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma*/drug therapy , Adenocarcinoma*/epidemiology , Adenocarcinoma*/pathology , Stomach Neoplasms*/drug therapy , Stomach Neoplasms*/epidemiology, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Female ; Humans ; Male ; Progression-Free Survival ; Registries

المؤلفون: Jiménez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, Avenida de Roma s/n, 33011, Oviedo, Spain. palucaji@hotmail.com., Carmona-Bayonas A; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, UMU, IMIB, Murcia, Spain., Sánchez Lorenzo ML; Medical Oncology Department, Hospital Universitario Central de Asturias, Avenida de Roma s/n, 33011, Oviedo, Spain., Plazas JG; Medical Oncology Department, Hospital General Universitario de Elche, Alicante, Spain., Custodio A; Medical Oncology Department, Hospital Universitario La Paz, Madrid, Spain., Hernández R; Medical Oncology Department, Hospital Universitario de Canarias, Santa Cruz De Tenerife, Spain., Garrido M; Medical Oncology Department, Pontificia Universidad Católica de Chile, Santiago De Chile, Chile., García T; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, UMU, IMIB, Murcia, Spain., Echavarría I; Medical Oncology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain., Cano JM; Medical Oncology Department, Hospital General de Ciudad Real, Ciudad Real, Spain., Rodríguez Palomo A; Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Mangas M; Medical Oncology Department, Hospital Galdakao-Usansolo, Usansolo, Spain., Macías Declara I; Medical Oncology Department, Hospital Universitario Parc Tauli, Sabadell, Spain., Ramchandani A; Medical Oncology Department, Hospital Universitario Insular de Gran Canaria, Las Palmas De Gran Canaria, Spain., Visa L; Medical Oncology Department, Hospital Universitario del Mar, Barcelona, Spain., Viudez A; Medical Oncology Department, Complejo Hospitalario de Navarra, Pamplona, Spain., Buxó E; Medical Oncology Department, Hospital Clínic, Barcelona, Spain., Díaz-Serrano A; Medical Oncology Department, Hospital Universitario Doce de Octubre, Madrid, Spain., López C; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Azkarate A; Medical Oncology Department, Hospital Universitario Son Espases, Mallorca, Spain., Longo F; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Castañón E; Medical Oncology Department, Clínica Universidad de Navarra, Pamplona, Spain., Sánchez Bayona R; Medical Oncology Department, Clínica Universidad de Navarra, Pamplona, Spain., Pimentel P; Medical Oncology Department, Hospital Santa Lucía, Cartagena, Spain., Limón ML; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Seville, Spain., Cerdá P; Medical Oncology Department, Instituto Oncológico Teknon, Barcelona, Spain., Álvarez Llosa R; Medical Oncology Department, Complejo Hospitalario de Orense, Ourense, Spain., Serrano R; Medical Oncology Department, Hospital Universitario Reina Sofía de Córdoba, Córdoba, Spain., Lobera MPF; Medical Oncology Department, Hospital Universitario Miguel Servet de Zaragoza, Zaragoza, Spain., Alsina M; Medical Oncology Department, Hospital Universitario Vall d'Hebron and VHIO-Vall d'Hebron Institute of Oncology, Barcelona, Spain., Hurtado Nuño A; Medical Oncology Department, Hospital Universitario Fundación Alcorcon, Madrid, Spain., Gómez-Martin C; Medical Oncology Department, Hospital Universitario Doce de Octubre, Madrid, Spain.

المصدر: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association [Gastric Cancer] 2017 May; Vol. 20 (3), pp. 465-474. Date of Electronic Publication: 2016 Sep 06.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 100886238 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1436-3305 (Electronic) Linking ISSN: 14363291 NLM ISO Abbreviation: Gastric Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*metabolism , Receptor, ErbB-2/*metabolism , Stomach Neoplasms/*metabolism , Stomach Neoplasms/*mortality, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Prognosis ; Proportional Hazards Models ; Spain ; Stomach Neoplasms/drug therapy ; Stomach Neoplasms/pathology ; Trastuzumab/administration & dosage

المؤلفون: Kalinka-Warzocha E; Wojewodzki Szpital, Pabianicka 62, 93-513, Lodz, Poland, ewakalinka@wp.pl., Plazas JG, Mineur L, Salek T, Hendlisz A, DeCosta L, Vogl FD, Passalacqua R

المصدر: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association [Gastric Cancer] 2015 Apr; Vol. 18 (2), pp. 360-7. Date of Electronic Publication: 2014 May 05.

نوع المنشور: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 100886238 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1436-3305 (Electronic) Linking ISSN: 14363291 NLM ISO Abbreviation: Gastric Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma/*drug therapy , Antineoplastic Combined Chemotherapy Protocols/*adverse effects , Granulocyte Colony-Stimulating Factor/*administration & dosage , Neutropenia/*chemically induced , Neutropenia/*drug therapy , Stomach Neoplasms/*drug therapy, Adenocarcinoma/secondary ; Disease Management ; Female ; Follow-Up Studies ; Humans ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Staging ; Prognosis ; Prospective Studies ; Stomach Neoplasms/pathology

المؤلفون: Santasusana JM; Departamento de Oncología Médica, Hospital Clínic, Barcelona, Spain., García López JL, García JJ, Carbonero AI, Plazas JG, Rovira PS, Martos CF, Guzmán MC, Jericó JF, Delgado FJ, Espinosa JC, Muñoz ML, Aguilar EA, Valera JS, García Ribas I, Mena AC

المصدر: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2005 Dec; Vol. 7 (11), pp. 493-8.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print Cited Medium: Print ISSN: 1699-048X (Print) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Pancreatic Neoplasms/*drug therapy, Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Deoxycytidine/administration & dosage ; Deoxycytidine/adverse effects ; Deoxycytidine/analogs & derivatives ; Disease-Free Survival ; Drug Administration Schedule ; Female ; Fluorouracil/administration & dosage ; Fluorouracil/adverse effects ; Follow-Up Studies ; Humans ; Hyperbilirubinemia/chemically induced ; Infusions, Intravenous ; Male ; Middle Aged ; Mucositis/chemically induced ; Neutropenia/chemically induced ; Pancreatic Neoplasms/pathology ; Patient Compliance ; Quality of Life ; Spain ; Survival Analysis ; Treatment Outcome ; Gemcitabine